Mission
PrecisionLife seek to provide the deepest disease biology insights on the planet – using cutting edge technology to identify new biomarkers and drug targets in chronic disease.
The Value Proposition
The PrecisionLife team leverage a unique data science platform to support precision drug discovery and drug repurposing. Partnering with life sciences companies, PrecisionLife employ their data analytics technology to accelerate discovery of new targets, repurpose existing compounds, and enhance precision throughout the drug discovery pipeline.
Our Analysis
Impact & Milestones
Precisionlife have successfully closed [X number of] revenue-generating partnerships with [£xM potential]. The company have also ensured robust IP protection through [Julien to provide detail on patents].
Why Alt. Club & PrecisionLife?
PrecisionLife were the first [?Julien to confirm] partner Alt.Club chose to work with. The pedigree of the founders, trajectory to date, and IP protection provide a deeply compelling, credible proposition.
Risks & Challenges
The drug discovery market is inherently competitive. The barriers to entry for companies in this space are low. The biomarker real-world impact, and economic case, is subject to change as global health systems have increasingly challenging financial positions.
Please contact us for more more detailed due diligence
Leadership Team
Dr Steve Gardener
CEO / Co-Founder
A serial technology entrepreneur with over 30 years’ experience developing and commercializing ground-breaking data science and informatics in the healthcare, life sciences and agri-food sectors.
Ray Pawlicki
Executive Chairman
Over 20 years of experience across leading global consumer, science, and technology companies including Novartis, Biogen, Cytec Industries, PepsiCo, Citibank, and Hewlett Packard; currently non-executive at a number of organisations including Nanowear, Medrhythms, Umass, and Harvard Pilgrim.
Dr Gert Møller
CAO / Co-Founder
An entrepreneur with multiple patents and awards, and over 20 years of experience of driving new innovations in AI, precision medicine and digital health.
[insert quote here]
- Steve Gardener, CEO